CarolynMDrazinicMDPhD, MBA
Psychiatry • Tallahassee, FLAddiction, Forensic Psychiatry, Neuropsychiatry, Psychopharmacology
Associate Professor Department of Clinical Sciences Florida State University Tallahassee, Florida
Dr. Drazinic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Florida State University
600 W College Ave
Tallahassee, FL 32306Phone+1 850-513-7058
Education & Training
University of MiamiExecutive MBA, anticipated December 2017, Healthcare, 2016 - 2017
Yale-New Haven Medical CenterFellowship, Forensic Psychiatry, 2002 - 2003- Yale-New Haven Medical CenterResidency, Psychiatry, 1998 - 2002
University of Florida College of MedicineClass of 1998
Certifications & Licensure
CT State Medical License 2000 - 2025
FL State Medical License 2014 - 2025- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Forensic Psychiatry
- American Board of Preventive Medicine Addiction Medicine
- American Board of Addiction MedicineDiplomate
Awards, Honors, & Recognition
- CMO of Psychiatry Jackson Health System, 2015-2016
- President Connecticut Psychiatric Society, 2013
- Chair, Mentorship Committee Society of Biological Psychiatry, 2013
- Join now to see all
Clinical Trials
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
- Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease Start of enrollment: 2016 May 10
Publications & Presentations
PubMed
- 15 citationsSafety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.Michael J Brownstein, Neal G. Simon, Jeffrey D. Long, Jon W. Yankey, Hilda T Maibach
Journal of Clinical Medicine. 2020-11-16 - 50 citationsClinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders.Karen E. Anderson, Erik van Duijn, David Craufurd, Carolyn Drazinic, Mary Edmondson
Journal of Huntington's Disease. 2018-01-01 - 9 citationsRapid array-based genomic characterization of a subtle structural abnormality: a patient with psychosis and der(18)t(5;18)(p14.1;p11.23).Carolyn M. Drazinic, Adife Gulhan Ercan-Sencicek, Laura M. Gault, Fuki M. Hisama, Mazin B. Qumsiyeh
American Journal of Medical Genetics. Part A. 2005-04-30
Press Mentions
Carolyn M. Drazinic, MD, PhD, MBA, a Psychiatrist with the Florida Mental Health Treatment Facility for the FlNovember 8th, 2019
Esteemed Psychiatrist, Carolyn M. Drazinic, MD, PhD, Is to Be Recognized as a 2017 Top Doctor in Coral Gables, FloridaAugust 18th, 2017- Esteemed Psychiatrist, Carolyn M. Drazinic, MD, PhD, Will Be Featured in the Leading Physicians of the WorldNovember 7th, 2016
Professional Memberships
- Fellow
- American College of Physician ExecutivesMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
